The Federal Trade Commission has issued warning letters to 24 of the nation’s largest healthcare services companies, putting major hospital and health-system operators on notice that patient pricing practices remain a live consumer-protection priority. Although the agency has not filed an enforcement action, the letters are legally significant: they serve as a public signal that the FTC is scrutinizing whether providers’ pricing disclosures, estimates, and patient-facing cost information could mislead consumers.

The message from FTC leadership is straightforward.